EpiSign and Geneyx Announce Partnership to Integrate Genomic and Epigenomic Analysis for Rare Disease

Contributed by: PR Newswire

Tags

Geneyx-EpiSign-Partne

More Like This

PR Newswire associated0

Epigenica AB Launches the Groundbreaking EpiFinder™ GenomePro - Unlocking the Epigenome with Unprecedented High Throughput and Multiplexing Features

PR Newswire associated0

Zymo Research Announces Strategic Partnership with biomodal to Deliver Next-Gen Multiomic Insights

MGI Tech Showcases Expanding Genomics Ecosystem at ESHG 2026 with New IVD Partnering Program and OEM Collaborations

PR Newswire associated0

MGI Tech and SeqOne Partner to Advance End-to-end Genomic Analysis

PR Newswire associated0

MGI Tech and Eurofins Genomics Partner to Elevate Precision Health with Revolutionary DNBSEQ-T20×2 Sequencer and Related Technologies

biomodal Delivers the 6-Base Genome with a Powerful New Multiomic Solution, duet evoC

PR Newswire associated0

MGI Tech and OncoDNA join forces to offer laboratories a streamlined NGS workflow for implementing Comprehensive Genomic Profiling (CGP) OncoDEEP® Kit in clinical practice

American College of Medical Genetics and Genomics (ACMG) Clinical Genetics Meeting: Genomics presents new research highlighting underdiagnosis of rare genetic disorders